ClinicalTrials.gg
RecruitingNCT07663500Updated Jun 23, 2026

Integrated Intrapartum Supportive Care and Pushing Strategies in Women Receiving Low-Dose Epidural Analgesia

An interventional study of Integrated Care with Immediate Pushing and Integrated Care with Spontaneous Pushing Group in Labor, Obstetric, Epidural Analgesia, Obstetric and Labor Duration, sponsored by National Taipei University of Nursing and Health Sciences. Recruiting at 1 site in Taiwan. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-23.

Sponsored by National Taipei University of Nursing and Health Sciences · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as recruiting.
  • Registered 1 year after the study started (first participant enrolled Jun 2025, registered Jun 2026).
  • Started Jun 2025; still recruiting 1 year 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
159
Allocation
Non-randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This prospective, three-arm, non-randomized quasi-experimental study aims to evaluate integrated intrapartum supportive care combined with different pushing strategies among women at 37-42 weeks of gestation who receive low-dose epidural analgesia. Participants receive integrated intrapartum supportive care combined with spontaneous pushing, integrated intrapartum supportive care combined with immediate pushing, or routine intrapartum care combined with immediate pushing. The primary outcomes are the durations of the first and second stages of labor. Secondary outcomes include mode of birth, obstetric interventions, maternal outcomes, and neonatal outcomes.

Read the detailed description

Participants are enrolled into one of three predefined care groups: (1) integrated intrapartum supportive care combined with spontaneous pushing (IC-SP), (2) integrated intrapartum supportive care combined with immediate pushing (IC-IP), or (3) routine intrapartum care combined with immediate pushing (RC-IP). Group allocation is determined prospectively according to the attending physician's established clinical practice. The RC-IP group receives the hospital's usual intrapartum care. Allocation is determined before implementation of the intervention and is not based on labor outcomes.

02

Conditions studied

  • Labor, Obstetric
  • Epidural Analgesia, Obstetric
  • Labor Duration

Keywords

  • Integrated intrapartum supportive care
  • Spontaneous pushing
  • Immediate pushing
  • Low-dose epidural analgesia
  • Maternal mobility
  • Labor progression
03

In context

Lead sponsor

National Taipei University of Nursing and Health Sciences is the lead sponsor of 124 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:low-risk pregnant women aged 18 years or older with a singleton, term pregnancy (37-42 weeks), spontaneous labor onset, and planning to receive low-dose epidural analgesia.

Exclusion Criteria: Exclusion Criteria: multiple gestation, non-cephalic presentation, known major fetal anomalies, planned cesarean birth, to vaginal birth, contraindications to maternal mobility or epidural analgesia, or inability to provide .

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
159 participants (estimated)

Study arms

  • Experimental
    Integrated Care with Spontaneous Pushing

    Integrated Care with Spontaneous Pushing Group

    Behavioral: Integrated Care with Spontaneous Pushing Group

  • Experimental
    Integrated Care with Immediate Pushing

    Integrated Care with Immediate Pushing Group

    Behavioral: Integrated Care with Immediate Pushing

  • Active comparator
    Standard Routine Care

    Standard Routine Care

    Behavioral: Standard Routine Care

Interventions

  • BehavioralIntegrated Care with Immediate Pushing

    Integrated Care with Immediate Pushing Group: Participants receive an integrated intrapartum care package that includes continuous labor support and active birth positioning. Once full cervical dilation is achieved, participants are instructed to begin pushing immediately, regardless of the presence or absence of an urge to push. This directive approach to second-stage labor is guided by midwives or obstetric staff.

  • BehavioralIntegrated Care with Spontaneous Pushing Group

    Participants receive the integrated intrapartum supportive care program during the first stage of labor. During the second stage, participants are encouraged to begin pushing in response to their spontaneous urge to push rather than routinely initiating pushing immediately after full cervical dilation. The pushing strategy is implemented by the attending clinical care team according to the predefined group protocol.

  • BehavioralStandard Routine Care

    Participants receive routine intrapartum care according to institutional clinical practice. Supportive measures and position changes may be provided according to maternal needs and clinical judgment, but participants do not receive the structured multicomponent integrated intrapartum supportive care program. During the second stage of labor, pushing begins after full cervical dilation according to the attending clinical team's immediate pushing practice.

06

What researchers measure

Primary outcomes

  1. Duration of the first and second stages of labor

    The duration of the first stage of labor is defined as the time interval from the onset of active labor-marked by regular, painful uterine contractions and cervical dilation of ≥6 cm-until full cervical dilation (10 cm). The duration of the second stage of labor is defined as the time from full cervical dilation to the complete delivery of the fetus. Labor durations will be recorded in minutes based on partograph entries and electronic medical records, with all timings verified by attending midwives or obstetric care providers to ensure accuracy.

    Time frame: From the onset of active labor to the delivery of the fetus.

Secondary outcomes

  1. Caesarean Section Rate

    The proportion of enrolled participants who undergo unplanned cesarean birth during labor or delivery. Indications for cesarean birth will be extracted from the medical record.

    Time frame: During labor and delivery

  2. Instrumental Vaginal Delivery Rate

    The proportion of participants who undergo instrumental vaginal delivery using forceps or vacuum extraction. The use of instruments will be recorded based on delivery records, and indications will be documented when available.

    Time frame: During delivery

  3. Augmentation Rate

    The proportion of participants who receive augmentation of labor after spontaneous onset. Administration details (timing, dosage, indication) will be obtained from medical records and partographs.

    Time frame: During labor

07

Study locations

1 of 1 sites recruiting
  • Taiwan Adventist Hospital
    Taipei, 10556, Taiwan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — This study does not plan to share individual participant data.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07663500
Responsible party
Wan-Lin Pan (Associate Professor, National Taipei University of Nursing and Health Sciences) — Principal investigator
First posted
Jun 23, 2026
Start date
Jun 10, 2025
Primary completion
Jul 31, 2026 (estimated)
Completion
Jul 31, 2026 (estimated)
Last update
Jun 23, 2026

Study contacts

Wan-Lin Pan, PhD
Contact
wanlimp@gmail.com
+886-2-2822-7101 ext. 7101
Wan-Lin Pan, PhD
principal investigator · National Taipei University of Nursing and Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion